1-20 of 20
Authors: A Patel
Journal Article
P1035 The Effects of an Intermittent Reduced Calorie Diet on Crohn’s Disease Free
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1909–i1910, https://doi.org/10.1093/ecco-jcc/jjae190.1209
Published: 22 January 2025
Journal Article
DOP033 Pre-Clinical Development of SL-325, a High Affinity DR3 Blocking Antibody, for Durable Blockade of the DR3/TL1A Axis in Inflammatory Bowel Disease Free
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i146, https://doi.org/10.1093/ecco-jcc/jjae190.0072
Published: 22 January 2025
Journal Article
P0705 Features of optimal disease control in Crohn’s disease and Ulcerative Colitis: Views on IBD Expectations and Well-being by Patients and Treatment providers Free
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1376–i1377, https://doi.org/10.1093/ecco-jcc/jjae190.0879
Published: 22 January 2025
Journal Article
P0864 Real-world effectiveness of upadacitinib for perianal Crohn’s disease: A multi-center retrospective study Free
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Pages i1642–i1644, https://doi.org/10.1093/ecco-jcc/jjae190.1038
Published: 22 January 2025
Journal Article
P052 Mucosal IgG-like naive B-cell expansion and maturation contribute to ulcerative colitis pathogenesis Free
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Page i314, https://doi.org/10.1093/ecco-jcc/jjad212.0182
Published: 24 January 2024
Journal Article
P313 Understanding Inflammatory Bowel Disease patients’ experiences, expectations, and insights in identifying and managing anxiety and depression. Free
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i453–i454, https://doi.org/10.1093/ecco-jcc/jjac190.0443
Published: 30 January 2023
Journal Article
DOP42 Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with moderately-to-severely active Ulcerative Colitis: 12-week results from the Phase 2 LATTICE-UC study Free
Journal of Crohn's and Colitis, Volume 16, Issue Supplement_1, January 2022, Pages i091–i092, https://doi.org/10.1093/ecco-jcc/jjab232.081
Published: 21 January 2022
Journal Article
P329 Which should come first? Surgery or biologic therapy for ileocaecal Crohn’s disease in biologic naïve patients Free
Journal of Crohn's and Colitis, Volume 16, Issue Supplement_1, January 2022, Pages i348–i349, https://doi.org/10.1093/ecco-jcc/jjab232.456
Published: 21 January 2022
Journal Article
P402 Incidence and outcomes of herpes zoster in the ozanimod phase, 3 ulcerative colitis and relapsing multiple sclerosis clinical program Free
Journal of Crohn's and Colitis, Volume 16, Issue Supplement_1, January 2022, Pages i395–i396, https://doi.org/10.1093/ecco-jcc/jjab232.529
Published: 21 January 2022
Journal Article
P392 To study the prevalence of depression and anxiety in patients of Inflammatory Bowel Disease (IBD) and the efficacy of psychopharmacotherapy in these patients: A pilot study Free
Journal of Crohn's and Colitis, Volume 16, Issue Supplement_1, January 2022, Page i389, https://doi.org/10.1093/ecco-jcc/jjab232.519
Published: 21 January 2022
Journal Article
P476 Disease recurrence patterns in patients undergoing bowel resections for Crohn’s disease Free
Journal of Crohn's and Colitis, Volume 16, Issue Supplement_1, January 2022, Page i446, https://doi.org/10.1093/ecco-jcc/jjab232.603
Published: 21 January 2022
Journal Article
P118 Magnetic resonance enterograghy in operative planning for patients with Crohn’s disease of the small bowel: does timing matter? Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S147, https://doi.org/10.1093/ecco-jcc/jjy222.242
Published: 25 January 2019
Journal Article
P344 Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S274–S275, https://doi.org/10.1093/ecco-jcc/jjy222.468
Published: 25 January 2019
Journal Article
P407 Real-world safety of tofacitinib in inflammatory bowel diseases: a multi-centre study Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S312–S313, https://doi.org/10.1093/ecco-jcc/jjy222.531
Published: 25 January 2019
Journal Article
P287 The clinical utility of low radiation dose computed tomography as a first-line investigation for evaluation of small bowel pathology Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S243, https://doi.org/10.1093/ecco-jcc/jjy222.411
Published: 25 January 2019
Journal Article
P361 Patterns of use and durability of initial and sequential biological agents in a large Paediatric inflammatory bowel disease observational cohort Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Pages S286–S287, https://doi.org/10.1093/ecco-jcc/jjx180.488
Published: 16 January 2018
Journal Article
P602 Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Pages S413–S414, https://doi.org/10.1093/ecco-jcc/jjx180.729
Published: 16 January 2018
Journal Article
DOP048 Vedolizumab levels during induction are associated with long-term clinical and endoscopic remission in patients with inflammatory bowel disease Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Pages S064–S065, https://doi.org/10.1093/ecco-jcc/jjx180.085
Published: 16 January 2018
Journal Article
P511 Baseline characteristics of ulcerative colitis patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (01) Get access
Journal of Crohn's and Colitis, Volume 11, Issue suppl_1, February 2017, Pages S339–S340, https://doi.org/10.1093/ecco-jcc/jjx002.635
Published: 26 January 2017
Journal Article
DOP020 Higher vedolizumab levels are associated with deep remission in patients with Crohn's disease and ulcerative colitis on maintenance therapy with vedolizumab Get access
Journal of Crohn's and Colitis, Volume 11, Issue suppl_1, February 2017, Page S38, https://doi.org/10.1093/ecco-jcc/jjx002.057
Published: 26 January 2017
